HSA
TMDX icon

Hussman Strategic Advisors’s Transmedics TMDX Stock Holding History

Hussman Strategic Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.13M Buy
31,500
+16,800
+114% +$2.19M 0.68% 26
2025
Q4 		$1.79M Buy
+14,700
New +$1.84M 0.43% 109

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hussman Strategic Advisors's TMDX Position: Q1 2026 in Review

Hussman Strategic Advisors increased its Transmedics (TMDX) stake by 114% in Q1 2026, buying an estimated $2.19M and bringing the position to 31,500 shares worth $3.13M. The position accounts for 0.68% of the portfolio, ranked #26.

Hussman Strategic Advisors first reported a position in TMDX in Q4 2025 and has held it in 2 quarters since. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Hussman Strategic Advisors held 31,500 shares of Transmedics worth $3.13M as of Q1 2026.
  • Hussman Strategic Advisors bought 16,800 Transmedics shares in Q1 2026, an estimated $2.19M.
  • Transmedics made up 0.68% of Hussman Strategic Advisors's portfolio in Q1 2026, its #26 holding.
  • Hussman Strategic Advisors first reported a position in Transmedics in Q4 2025 and has held it in 2 quarters since.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Hussman Strategic Advisors's 13F filing for Q1 2026, filed 11 May 2026.